Literature DB >> 33252616

Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine.

Natalie McCormick1, Zachary S Wallace1, Chio Yokose1, April Jorge1, Chana A Sacks2, John Hsu3, Hyon K Choi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33252616      PMCID： PMC7851728          DOI： 10.1001/jamainternmed.2020.5017

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  The colchicine debacle.

Authors:  B Joseph Guglielmo
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

2.  Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.

Authors:  Aaron S Kesselheim; Jessica M Franklin; Seoyoung C Kim; John D Seeger; Daniel H Solomon
Journal:  J Gen Intern Med       Date:  2015-04-09       Impact factor: 5.128

3.  Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

Authors:  Jean-Claude Tardif; Simon Kouz; David D Waters; Olivier F Bertrand; Rafael Diaz; Aldo P Maggioni; Fausto J Pinto; Reda Ibrahim; Habib Gamra; Ghassan S Kiwan; Colin Berry; José López-Sendón; Petr Ostadal; Wolfgang Koenig; Denis Angoulvant; Jean C Grégoire; Marc-André Lavoie; Marie-Pierre Dubé; David Rhainds; Mylène Provencher; Lucie Blondeau; Andreas Orfanos; Philippe L L'Allier; Marie-Claude Guertin; François Roubille
Journal:  N Engl J Med       Date:  2019-11-16       Impact factor: 91.245

4.  Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.

Authors:  Thomas J Hwang; Nina Jain; Julie C Lauffenburger; Kerstin N Vokinger; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

5.  Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.

Authors:  Jing Luo; John D Seeger; Macarius Donneyong; Joshua J Gagne; Jerry Avorn; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.